EATRIS Translational Medicine 2017
EATRIS is organising its third bi-annual conference, 'Translational Medicine 2017' over 24-26 September in Prague. This event will bring together international experts to discuss the latest advancements in translational medicine.
The theme of this third edition will be “Enhancing Predictivity in Medicines Development” and will focus on bringing together the latest approaches to increase chances of success in drug development, from novel in vitro systems to new biomarkers or clinical trial methodology for patient selection and stratification.
The conference will start on Sunday, September 24 with a series of educational workshops. The workshops will be dedicated to key topics in the ﬁeld such as molecular imaging, biomarker validation or potency assays for ATMP’s and vaccines.
Please note that space is limited to 25 persons per workshop and registration is on first-come, first-serve basis.
For the main conference on September 25 and 26, the event will be structured around 3 plenary sessions, introduced by keynote speakers:
- Session 1: The Funder, Developer and Regulator as Partners in Innovation
- Session 2: Novel approaches in clinical development
- Session 3: Developing more predictive preclinical tools to better reach proof of concept
For this year’s edition, attendees will hear from – among others – Mark Schmidt (Senior Director, Janssen Research and Development), Philip Murphy (Head, Experimental Medicine Imaging, GSK), Christopher Austin (NIH-NCATS, United States).